EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice—Commentary Based on a Virtual Focus Group

Giuseppe Curigliano, Luís Castelo-Branco, Volkmar Müller, Nadia Harbeck

Clinical Breast Cancer · 2026-11 · 26 (11) · 74-82

DOI: 10.1016/j.clbc.2026.10.003 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Breast Cancer, 2026-11. Verfasst von Giuseppe Curigliano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy; European Institute of Oncology, IRCCS, Milano, Italy. Electronic add…. Hauptthemen laut MEDLINE: Breast Neoplasms, Practice Guidelines as Topic, Antineoplastic Combined Chemotherapy Protocols, Medical Oncology. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AstraZeneca PLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPractice Guidelines as TopicAntineoplastic Combined Chemotherapy ProtocolsMedical OncologyHumansFemaleEuropeBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesMolecular Targeted TherapyNeoplasm Metastasis

Stichwörter der Autor:innen

Biomarker testingESMO guidelinesHER2-positive breast cancerHormone receptor–positive breast cancerTriple-negative breast cancer (TNBC)

Substanzen

Biomarkers, TumorErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy; European Institute of Oncology, IRCCS, Milano, Italy. Electronic address: giuseppe.curigliano@ieo.it.
  • Faculdade de Ciências Médica, Nova Medical School, Lisbon, Portugal.
  • Department of Gynecology and University Breast Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Breast Centre, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany.

Förderung

  • AstraZeneca PLC

Zitieren

APA

Curigliano, G., Castelo-Branco, L., Müller, V., & Harbeck, N. (2026). 2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice—Commentary Based on a Virtual Focus Group. Clinical Breast Cancer, 26(11), 74-82. https://doi.org/10.1016/j.clbc.2026.10.003

Vancouver

Curigliano G, Castelo-Branco L, Müller V, Harbeck N. 2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice—Commentary Based on a Virtual Focus Group. Clinical Breast Cancer. 2026;26(11):74-82. doi:10.1016/j.clbc.2026.10.003

BibTeX
@article{Curigliano2026,
  author = {Curigliano, Giuseppe and Castelo-Branco, Luís and Müller, Volkmar and Harbeck, Nadia},
  title = {2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice—Commentary Based on a Virtual Focus Group},
  journal = {Clinical Breast Cancer},
  year = {2026},
  volume = {26},
  number = {11},
  pages = {74--82},
  doi = {10.1016/j.clbc.2026.10.003}
}
Kostenlos starten →